Exclusives
FacebookTwitterLinkedInGoogle+RSS Feed
Fire EMSEMS TodayEMS Insider

Defibtech Announces AED Battery Pack Recall

Defibtech, LLC, is initiating a voluntary recall of 5,418 DBP-2800 Battery Packs used in the Lifeline AED® and ReviveR AEDTM (semi-automatic external defibrillators). This recall affects all DBP- 2800 Battery Packs shipped prior to June 4, 2007. In rare instances, when the AED is used with an affected battery pack, the AED may falsely detect an error condition during charging for a shock, then cancel charge and not provide therapy. Defibtech determined the need for this recall after learning of four reports from end users of this malfunction during patient use.

The company has identified recommendations for the end customer to follow until the battery pack has been corrected, which allows the battery pack to remain in service. A copy of these recommendations is being mailed to all affected customers. This customer notification, as well as instructions on determining whether a battery pack is affected, can also be found on the www.defibtech.com/batteryFA1 web page. For additional information regarding this recall, please refer to the above referenced web page, contact your distributor, or contact Defibtech at techsupport@defibtech.com, 1-877-453-4507 or 1- 203-453-4507.

Defibtech will provide customers with a free battery pack update card to address this issue for all affected battery packs. The correction to the battery pack will be able to be performed at the location where the battery pack is deployed using any DDU-100 series AED and a Defibtech supplied battery pack update card. The battery pack update is expected to be available within the next two weeks.

The DBP-2800 battery packs affected by this recall have been distributed globally to fire departments, EMS, health clubs, schools, and other organizations. The affected battery packs are used in AEDs which can be identified by the words "Lifeline AED®" and "ReviveR AEDTM" on the front of the device.

The Food and Drug Administration (FDA) has determined that this action is a Class I recall. Any adverse reactions experienced with the use of this product and/or quality problems should also be reported to the FDA’s MedWatch Program by phone at 1-800- FDA-1088, or on the MedWatch website at www.fda.gov/medwatch2.



RELATED ARTICLES

More Rural Hospitals Closing

A growing number of facilities across the country face growing difficulties.

Milwaukee Launches Community Paramedic Program

Pilot program with University of Wisconsin-Milwaukee looks at follow-up care.

Cherokee Nation EMS Paramedic Training Named Top in Industry

Program is first and only tribe to receive accreditation from Commission on Accreditation of Allied Health Education Programs.

Colorado Residents to Benefit in Ambulance Contract Split

Change in contract for Colorado Springs is seen a way for faster response times and increased funds.

FDNY Graduates Over 100 New EMTs

Seven foreign languages are spoken among the new personnel.

Teen Rescued Five Days after Nepal Quake

Victim pulled from rubble of seven-story building.

Features by Topic

JEMS Connect

CURRENT DISCUSSIONS

 
 

EMS BLOGS

Blogger Browser

Today's Featured Posts

Featured Careers